# Assessing Ocular Surface Changes After Changing Glaucoma Medications

> **NCT00554411** · — · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 22 (actual)

## Conditions studied

- Glaucoma
- Monotherapy With Xalatan From 1 to 18 Months
- Ocular Surface Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00554411
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2017-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00554411

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00554411, "Assessing Ocular Surface Changes After Changing Glaucoma Medications". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00554411. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*